- Enrollment
- 60
- Started
- Feb 2024
- Completion
- Nov 2025
- Locations
- 1
- Countries
- 1
- Updated
- Dec 2023
Industry sponsor intelligence
Pharmbio Korea Co., Ltd.Clinical Pipeline.
Lead-sponsor view of Pharmbio Korea Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 60
Pipeline overview
Programs by phase and activity.
Velocity
Pharmbio Korea Co., Ltd. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 31
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Abaloparatide → | 1 | 0 | 0 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Pharmbio Korea Co., Ltd. studies.
This page groups studies where Pharmbio Korea Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates